What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?

Jonathan Douxfils; Justine Baudar; Bérangère Devalet; Meyer Michel Samama; Bernard Chatelain; Jean-Michel Dogne; François Mullier

What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?

Jonathan Douxfils, Justine Baudar, Bérangère Devalet, Meyer Michel Samama, Bernard Chatelain, Jean-Michel Dogne, François Mullier

Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Journal of Thrombosis and Haemostasis. 2014 Jun;12 Suppl 1:1-117
Publication status	Published - 2014
Event	60th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis - Milwaukee, United States Duration: 23 Jun 2014 → 26 Jun 2014

Scientific committee

Scientific committee	60th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis
Country/Territory	United States
City	Milwaukee
Period	23/06/14 → 26/06/14

Cite this

@inproceedings{dcce1f234dbb4be19ee5d0c852f3bb56,

title = "What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?",

author = "Jonathan Douxfils and Justine Baudar and B{\'e}rang{\`e}re Devalet and Samama, {Meyer Michel} and Bernard Chatelain and Jean-Michel Dogne and Fran{\c c}ois Mullier",

year = "2014",

language = "English",

booktitle = "Journal of Thrombosis and Haemostasis. 2014 Jun;12 Suppl 1:1-117",

note = "60th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis ; Conference date: 23-06-2014 Through 26-06-2014",